Abstract
It is urgent to discover new antimicrobials to control bacterial and fungal infectious diseases, such as those caused by Mycobacterium tuberculosis (Mtb), Aspergillus fumigatus, Paracoccidioides brasiliensis and Candida auris. The increasing emergence of multidrug-resistant strains and the high systemic toxicity of current treatments further limit the therapeutic options for these infecti…